- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Pfizer net profit falls 6pc to Rs 103.01 crore in Q4
New Delhi: Drug firm Pfizer Ltd on Monday reported a 5.90 per cent decline in net profit at Rs 103.01 crore for the quarter ended March 31, 2020.
The company had posted a net profit of Rs 109.47 crore in the corresponding period of the previous fiscal, Pfizer said in a filing to the BSE.
Revenue from operations stood at Rs 502.01 crore for the quarter under consideration. It was at Rs 535.66 crore in the same period a year ago, it added.
For 2019-20, the company''s net profit stood at Rs 509.13 crore as against Rs 429.05 crore in 2018-19, Pfizer said.
The company''s revenue from operations stood at Rs 2,151.65 crore for the fiscal year ended March 2020. It was at Rs 2,081.50 crore in 2018-19.
The company''s board of directors have recommended a final dividend of Rs 10 per equity share of Rs 10 each for the financial year ended March 31, 2020, Pfizer said.
Shares of Pfizer Ltd on Monday closed 0.41 per cent higher at Rs 4,078.15 per scrip on the BSE.
Read also: Pfizer Abrocitinib hits mark in phase 3 of Atopic Dermatitis trial
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751